Bioloogiliste ravimite ostmine
Contracts total
7 141 250 €
Bids
3
Type
Supplies
Published
22.03.2024
Tender description
Käesoleva hanke eesmärk on sõlmida raamleping bioloogiliste ravimite ostmiseks HD Lisas 1 toodud nimetuste ja kirjelduste alusel.
Awarded contracts
28.05.2024| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| B06AC02 Icatibant | MAGNUM MEDICAL OÜ | 124 800 € | 3 | 23.05.2024 |
| L04AA23 Natalizumab | TAMRO EESTI OÜ | 59 612 € | 1 | 27.05.2024 |
| L04AA23 Natalizumab | TAMRO EESTI OÜ | 149 031 € | 1 | 27.05.2024 |
| L04AA25 Ekulizumab | TAMRO EESTI OÜ | 888 781 € | 1 | 27.05.2024 |
| L04AA43 Ravulizumab | TAMRO EESTI OÜ | 820 390 € | 1 | 27.05.2024 |
| L04AA34 Alemtuzumab | MAGNUM MEDICAL OÜ | 149 784 € | 2 | 23.05.2024 |
| L04AB06 Golimumab | MAGNUM MEDICAL OÜ | 543 140 € | 2 | 23.05.2024 |
| L04AB06 Golimumab | MAGNUM MEDICAL OÜ | 213 935 € | 2 | 23.05.2024 |
| L04AC03 Anakinra | TAMRO EESTI OÜ | 19 656 € | 2 | 27.05.2024 |
| L04AC05 Ustekinumab | TAMRO EESTI OÜ | 1 737 060 € | 3 | 27.05.2024 |
| L04AC07 Tocilizumab | Roche Eesti Osaühing | 15 798 € | 2 | 23.05.2024 |
| L04AC07 Tocilizumab | Roche Eesti Osaühing | 16 926 € | 2 | 23.05.2024 |
| L04AC07 Tocilizumab | Roche Eesti Osaühing | 11 284 € | 2 | 23.05.2024 |
| L04AC07 Tocilizumab | Roche Eesti Osaühing | 276 185 € | 2 | 23.05.2024 |
| L04AC07 Tocilizumab | Roche Eesti Osaühing | 118 365 € | 2 | 23.05.2024 |
| L04AC18 Risankizumab | MAGNUM MEDICAL OÜ | 128 914 € | 1 | 23.05.2024 |
| L04AC18 Risankizumab | MAGNUM MEDICAL OÜ | 572 954 € | 1 | 23.05.2024 |
| R03DX05 Omalizumab | TAMRO EESTI OÜ | 390 260 € | 2 | 27.05.2024 |
| R03DX09 Mepolizumab | TAMRO EESTI OÜ | 394 160 € | 2 | 27.05.2024 |
| R03DX10 Benralizumab | MAGNUM MEDICAL OÜ | 484 012 € | 1 | 23.05.2024 |
| R03DX11 Tesepelumab | MAGNUM MEDICAL OÜ | 26 202 € | 1 | 23.05.2024 |
Tender lots
21| Lot | Estimated value | Deadline |
|---|---|---|
| B06AC02 Icatibant | 26.04.2024 | |
| L04AA23 Natalizumab | 26.04.2024 | |
| L04AA23 Natalizumab | 26.04.2024 | |
| L04AA25 Ekulizumab | 26.04.2024 | |
| L04AA43 Ravulizumab | 26.04.2024 | |
| L04AA34 Alemtuzumab | 26.04.2024 | |
| L04AB06 Golimumab | 26.04.2024 | |
| L04AB06 Golimumab | 26.04.2024 | |
| L04AC03 Anakinra | 26.04.2024 | |
| L04AC05 Ustekinumab | 26.04.2024 | |
| L04AC07 Tocilizumab | 26.04.2024 | |
| L04AC07 Tocilizumab | 26.04.2024 | |
| L04AC07 Tocilizumab | 26.04.2024 | |
| L04AC07 Tocilizumab | 26.04.2024 | |
| L04AC07 Tocilizumab | 26.04.2024 | |
| L04AC18 Risankizumab | 26.04.2024 | |
| L04AC18 Risankizumab | 26.04.2024 | |
| R03DX05 Omalizumab | 26.04.2024 | |
| R03DX09 Mepolizumab | 26.04.2024 | |
| R03DX10 Benralizumab | 26.04.2024 | |
| R03DX11 Tesepelumab | 26.04.2024 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 2 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 2 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 3 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 5 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 9 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 9 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.